바이오디펜스 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 9.1%의 성장률로 287억 5,000만 달러에 달할 것으로 예측됩니다. 예측 기간의 성장은 새로운 전염병의 지속적인 출현, 생명 공학의 추가 도약, 세계 생물방어 노력을 지원하는 국제 협력 및 자금 조달 메커니즘 강화, 생물방어 인프라 구축 및 업그레이드, 생물방어에 대한 대중의 인식 및 교육 바이오디펜스 인프라 구축 및 업그레이드, 바이오디펜스에 대한 일반 대중의 인식 및 교육 향상, 혁신적인 바이오디펜스 기술을 지원하는 정책 및 규제 프레임워크의 지속적인 진화, 바이오디펜스 연구개발에 대한 민간 부문의 투자 증가 등이 주요 요인으로 작용할 것으로 보입니다. 예측 기간 동안 주요 동향으로는 예측 모델링, 위협 감지, 새로운 생물방어 도구 개발에 AI와 머신러닝 활용, 생물학적 위협의 조기 감지 및 관리를 위한 원격 의료 및 원격 모니터링 기술 통합, 차세대 백신 및 치료제 개발, AI 기반 신약 개발 및 개발, 유전체 모니터링, AI 기반 신약 개발 프로세스, 유전체 모니터링 및 데이터 분석 개선 등을 들 수 있습니다.
바이오디펜스 시장은 신종 감염병의 지속적인 위협으로 인해 성장이 예상됩니다. 박테리아, 바이러스, 기생충, 곰팡이 등 다양한 미생물에 의해 유발되는 이러한 질병은 생물방어 분야에서 병원체 통제, 신속한 대응 전략, 세계 조정 및 준비 태세에 대한 지속적인 과제를 부각시키고 있습니다. 생물방어는 생물학적 위협에 대한 대비, 조기 발견, 신속한 대응을 개선하여 감염병을 통제하고 공중보건에 미치는 영향을 줄이기 위해 매우 중요합니다. 예를 들어, 2023년 11월 세계보건기구(WHO)는 2022년 전 세계 결핵 환자 수를 약 1,060만 명으로 추산하여 전 세계 수백만 명에게 영향을 미칠 것으로 예상했습니다. 이러한 거듭되는 위협이 바이오디펜스 시장 성장의 원동력이 되고 있습니다.
생물학적 위험에 대한 전 세계 대비 태세를 강화하기 위해 생물방어 분야의 주요 기업들은 비강용 코로나19 백신과 같은 혁신적인 솔루션을 적극적으로 개발하고 있습니다. 비강 백신은 투여 용이성, 점막 면역 가능성, 주사 바늘에 대한 의존성 감소, 접근성 향상, 면역 반응 증가 가능성 등의 이점이 있습니다. 예를 들어, Bharat Biotech International Limited는 2023년 1월에 코로나19 비강 백신 iNCOVACC를 출시했습니다. 이 백신은 융합 전 안정화 스파이크 단백질을 가진 재조합 복제결손 아데노바이러스 벡터를 사용하여 개발되었으며, I, II, III상 시험이 성공적으로 완료되었습니다. 비강 점안제로 투여되며, 4주 간격으로 2회 접종하고 각 콧구멍에 4방울씩 떨어뜨립니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 바이오디펜스 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업 분석
- 세계의 바이오디펜스 시장 : 성장률 분석
- 세계의 바이오디펜스 시장 실적 : 규모와 성장, 2019-2024
- 세계의 바이오디펜스 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 바이오디펜스 전체 시장(TAM)
제6장 시장 세분화
- 세계의 바이오디펜스 시장 : 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 탄저균
- 천연두
- 보툴리눅스
- 방사선 또는 핵
- 기타 유형
- 세계의 바이오디펜스 시장 : 생물 위협 감지 기기별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 샘플러
- 검출기 또는 트리거 장비
- 식별자
- 어세이
- 기타 생물병기 감지 장비
- 세계의 바이오디펜스 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 병원 및 진료소
- 외래 진료 센터
- 기타 용도
- 세계의 바이오디펜스 시장 : 탄저균 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 탄저균 백신
- 탄저균 치료제
- 세계의 바이오디펜스 시장 : 천연두 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 천연두 백신
- 천연두 항바이러스제
- 세계의 바이오디펜스 시장 : 보툴리눅스 중독 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 보툴리눅스 항독소
- 보툴리누스균 백신
- 보툴리눅스 신경 독소 억제제
- 세계의 바이오디펜스 시장 : 방사선 또는 핵유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 방사선 방호약
- 의료 대책
- 세계의 바이오디펜스 시장 : 기타 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 리신
- 페스트
- 야토병
- 바이러스성 출혈열
- 기타 생물 독소 또는 생물 위협 물질
제7장 지역별/국가별 분석
- 세계의 바이오디펜스 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 바이오디펜스 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 바이오디펜스 시장 : 경쟁 구도
- 바이오디펜스 시장 : 기업 개요
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
- Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
- Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업 및 혁신 기업
- AstraZeneca Plc
- GSK plc
- Gilead Sciences Inc
- Biogen Inc
- Novavax Inc
- Ichor Medical Systems
- Emergent BioSolutions Inc.
- Alnylam Pharmaceuticals Inc.
- Dynavax Technologies
- Bavarian Nordic
- Siga Technologies Inc.
- Elusys Therapeutics Inc.
- Ology Bioservices
- Altimmune Inc.
- Hytest Limited
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 바이오디펜스 시장(2029년) : 새로운 기회를 제공하는 국가
- 바이오디펜스 시장(2029년) : 새로운 기회를 제공하는 부문
- 바이오디펜스 시장(2029년) : 성장 전략
제36장 부록
LSH
Biodefense encompasses strategies and measures aimed at safeguarding against biological threats, including intentional releases of pathogens or biotoxins. These efforts involve developing detection systems, vaccines, treatments, and emergency response plans to minimize the impact of biological attacks on public health and safety. Additionally, biodefense includes research and policies to prevent the misuse of biological agents.
The primary types of biodefense include anthrax, smallpox, botulism, radiation or nuclear threats, and others. Anthrax is a severe infectious disease caused by Bacillus anthracis, affecting humans and animals. It can be contracted through skin contact, inhalation, or ingestion of spores. Various biothreat detection devices, such as samplers, detectors, identifiers, assays, and more, are utilized in settings such as hospitals, clinics, ambulatory care centers, and beyond.
The biodefense research report is one of a series of new reports from The Business Research Company that provides biodefense market statistics, including the biodefense industry's global market size, regional shares, competitors with a biodefense market share, detailed biodefense market segments, market trends and opportunities, and any further data you may need to thrive in the biodefense industry. This biodefense market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The biodefense market size has grown strongly in recent years. It will grow from $18.55 billion in 2024 to $20.29 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to increased government investment in biodefense programs and initiatives, strengthening of regulatory frameworks to fast-track the approval of biodefense products and technologies, enhanced collaboration between government agencies, private sector companies, and academic institutions, rising geopolitical tensions and concerns over bioterrorism.
The biodefense market size is expected to see strong growth in the next few years. It will grow to $28.75 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to the continued emergence of new infectious diseases, further breakthroughs in biotechnology, strengthening of international collaboration and funding mechanisms to support global biodefense efforts building and upgrading biodefense infrastructure, increasing public awareness and education on biodefense, continued evolution of policies and regulatory frameworks to support innovative biodefense technologies, growing investment from the private sector in biodefense research and development. Major trends in the forecast period include leveraging AI and machine learning for predictive modeling, threat detection, and the development of new biodefense tools, integration of telehealth and remote monitoring technologies for early detection and management of biological threats, focus on the development of next-generation vaccines and therapeutics, AI-driven drug discovery and development processes, improved genomic surveillance and data analytics.
The biodefense market is anticipated to experience growth due to the persistent threat of emerging infectious diseases. These diseases, caused by various microorganisms such as bacteria, viruses, parasites, or fungi, highlight the ongoing challenges in pathogen control, rapid response strategies, global coordination, and readiness within the biodefense sector. Biodefense is crucial for managing infectious diseases by improving preparedness, early detection, and swift response to biological threats, thus mitigating their impact on public health. For example, in November 2023, the World Health Organization (WHO) estimated a global tuberculosis (TB) case count of around 10.6 million in 2022, affecting millions of individuals worldwide. This recurring threat underscores the driving force behind the growth of the biodefense market.
Leading companies in the biodefense sector are actively developing innovative solutions, such as nasal COVID-19 vaccines, to bolster global readiness against biological hazards. Nasal vaccines offer advantages such as easier administration, potential for mucosal immunity, reduced reliance on needles, increased accessibility, and potentially enhanced immune responses. For instance, Bharat Biotech International Limited launched the iNCOVACC Nasal COVID-19 vaccine in January 2023. This vaccine, developed using a recombinant replication-deficient adenovirus vector with a pre-fusion stabilized spike protein, underwent successful phase I, II, and III trials. Administered via nasal drops, it involves a 2-dose series given 4 weeks apart, with 4 drops into each nostril.
In September 2022, Emergent BioSolutions Inc. acquired worldwide rights to the TEMBEXA (brincidofovir) smallpox oral antiviral drug from Chimerix for $238 million. This acquisition underscores Emergent BioSolutions' commitment to advancing public health initiatives and addressing global health threats, particularly against smallpox outbreaks. Chimerix Inc., a biotechnology research company, is known for providing biodefense solutions.
Major companies operating in the biodefense market are Pfizer Inc., Johnson & Johnson, Merck & Co., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GSK plc, Gilead Sciences Inc, Biogen Inc, Novavax Inc, Ichor Medical Systems, Emergent BioSolutions Inc., Alnylam Pharmaceuticals Inc., Dynavax Technologies, Bavarian Nordic, Siga Technologies Inc., Elusys Therapeutics Inc., Ology Bioservices, Altimmune Inc., Hytest Limited, XOMA Corporation, Cleveland BioLabs Inc., Inovio Pharmaceuticals Inc, Dynport Vaccine Company, ViralClear Pharmaceuticals
North America was the largest region in the biodefense market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biodefense market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the biodefense market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The biodefense market consists of revenues earned by entities by providing services such as threat assessment, surveillance, training, consultation, strategy development, emergency planning, and facility management. The market value includes the value of related goods sold by the service provider or included within the service offering. The biodefense market also includes sales of detection equipment, personal protective gear, vaccines and pharmaceuticals, biological agent identification kits, biocontainment equipment, emergency response kits, biosecurity systems, and communication systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Biodefense Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on biodefense market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for biodefense ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biodefense market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Anthrax; Smallpox; Botulism; Radiation Or Nuclear; Other Types
- 2) By Biothreat Detection Device: Samplers; Detectors Or Triggering Devices; Identifiers; Assays; Other Biothreat Detection Devices
- 3) By Application: Hospitals And Clinics; Ambulatory Care Centers; Other Applications
- Subsegments:
- 1) By Anthrax: Bacillus Anthracis Vaccine; Anthrax Therapeutics
- 2) By Smallpox: Smallpox Vaccine; Antiviral Drugs For Smallpox
- 3) By Botulism: Botulism Antitoxin; Botulism Vaccine; Botulinum Neurotoxin Inhibitors
- 4) By Radiation Or Nuclear: Radiation Protection Drugs; Medical Countermeasures
- 5) By Other Types: Ricin; Plague; Tularemia; Viral Hemorrhagic Fevers; Other Biotoxins Or Biothreat Agents
- Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co.; Sanofi SA; Bristol-Myers Squibb Company
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Biodefense Market Characteristics
3. Biodefense Market Trends And Strategies
4. Biodefense Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Biodefense Growth Analysis And Strategic Analysis Framework
- 5.1. Global Biodefense PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Biodefense Market Growth Rate Analysis
- 5.4. Global Biodefense Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Biodefense Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Biodefense Total Addressable Market (TAM)
6. Biodefense Market Segmentation
- 6.1. Global Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Anthrax
- Smallpox
- Botulism
- Radiation Or Nuclear
- Other Types
- 6.2. Global Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Samplers
- Detectors Or Triggering Devices
- Identifiers
- Assays
- Other Biothreat Detection Devices
- 6.3. Global Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals And Clinics
- Ambulatory Care Centres
- Other Applications
- 6.4. Global Biodefense Market, Sub-Segmentation Of Anthrax, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Bacillus Anthracis Vaccine
- Anthrax Therapeutics
- 6.5. Global Biodefense Market, Sub-Segmentation Of Smallpox, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Smallpox Vaccine
- Antiviral Drugs For Smallpox
- 6.6. Global Biodefense Market, Sub-Segmentation Of Botulism, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Botulism Antitoxin
- Botulism Vaccine
- Botulinum Neurotoxin Inhibitors
- 6.7. Global Biodefense Market, Sub-Segmentation Of Radiation Or Nuclear, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Radiation Protection Drugs
- Medical Countermeasures
- 6.8. Global Biodefense Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Ricin
- Plague
- Tularemia
- Viral Hemorrhagic Fevers
- Other Biotoxins Or Biothreat Agents
7. Biodefense Market Regional And Country Analysis
- 7.1. Global Biodefense Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Biodefense Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Biodefense Market
- 8.1. Asia-Pacific Biodefense Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Biodefense Market
- 9.1. China Biodefense Market Overview
- 9.2. China Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Biodefense Market
- 10.1. India Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Biodefense Market
- 11.1. Japan Biodefense Market Overview
- 11.2. Japan Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Biodefense Market
- 12.1. Australia Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Biodefense Market
- 13.1. Indonesia Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Biodefense Market
- 14.1. South Korea Biodefense Market Overview
- 14.2. South Korea Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Biodefense Market
- 15.1. Western Europe Biodefense Market Overview
- 15.2. Western Europe Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Biodefense Market
- 16.1. UK Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Biodefense Market
- 17.1. Germany Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Biodefense Market
- 18.1. France Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Biodefense Market
- 19.1. Italy Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Biodefense Market
- 20.1. Spain Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Biodefense Market
- 21.1. Eastern Europe Biodefense Market Overview
- 21.2. Eastern Europe Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Biodefense Market
- 22.1. Russia Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Biodefense Market
- 23.1. North America Biodefense Market Overview
- 23.2. North America Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Biodefense Market
- 24.1. USA Biodefense Market Overview
- 24.2. USA Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Biodefense Market
- 25.1. Canada Biodefense Market Overview
- 25.2. Canada Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Biodefense Market
- 26.1. South America Biodefense Market Overview
- 26.2. South America Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Biodefense Market
- 27.1. Brazil Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Biodefense Market
- 28.1. Middle East Biodefense Market Overview
- 28.2. Middle East Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Biodefense Market
- 29.1. Africa Biodefense Market Overview
- 29.2. Africa Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Biodefense Market Competitive Landscape And Company Profiles
- 30.1. Biodefense Market Competitive Landscape
- 30.2. Biodefense Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
31. Biodefense Market Other Major And Innovative Companies
- 31.1. AstraZeneca Plc
- 31.2. GSK plc
- 31.3. Gilead Sciences Inc
- 31.4. Biogen Inc
- 31.5. Novavax Inc
- 31.6. Ichor Medical Systems
- 31.7. Emergent BioSolutions Inc.
- 31.8. Alnylam Pharmaceuticals Inc.
- 31.9. Dynavax Technologies
- 31.10. Bavarian Nordic
- 31.11. Siga Technologies Inc.
- 31.12. Elusys Therapeutics Inc.
- 31.13. Ology Bioservices
- 31.14. Altimmune Inc.
- 31.15. Hytest Limited
32. Global Biodefense Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Biodefense Market
34. Recent Developments In The Biodefense Market
35. Biodefense Market High Potential Countries, Segments and Strategies
- 35.1 Biodefense Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Biodefense Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Biodefense Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
